QIAGEN N.V.(NYSE:QGEN) stock News

QGEN Latest News, Press Relases and Analysis

All

Press Releases

3 days ago - By: Zacks Investment Research - Mentions: HOLX BSX

The Role of M&A in Hologic's Growth Story: Are More Deals in Sight?

12 days ago - By: Zacks Investment Research - Mentions: NVS INCY

INCY Stock Trading Close to Its 52-Week High: Buy, Sell or Hold?

21 days ago - By: Zacks Investment Research

Why Qiagen (QGEN) International Revenue Trends Deserve Your Attention

24 days ago - By: Benzinga - Mentions: APP CROX JACK TPC ...

DoorDash To Rally Around 30%? Here Are 10 Top Analyst Forecasts For Thursday

a month ago - By: Zacks Investment Research

Qiagen (QGEN) Reports Q2 Earnings: What Key Metrics Have to Say

a month ago - By: Benzinga - Mentions: AFG CXDO YUM PACK ...

Earnings Scheduled For August 5, 2025

a month ago - By: Zacks Investment Research - Mentions: DTIL

Qiagen (QGEN) Matches Q2 Earnings Estimates

a month ago - By: QIAGEN N.V.

QIAGEN exceeds outlook for Q2 2025 with solid growth and improved profitability

a month ago - By: QIAGEN N.V.

QIAGEN Expands NGS Portfolio with Launch of QIAseq xHYB Long Read Panels

4 months ago - By: Zacks Investment Research

Here's Why Qiagen (QGEN) is a Strong Value Stock

2 months ago - By: QIAGEN N.V.

QIAGEN N.V. to Release Results for Q2 2025 and Hold Webcast

2 months ago - By: QIAGEN N.V..

QIAGEN Announces Election of Stephen Rusckowski as Chairman of Supervisory Board

2 months ago - By: Yahoo Finance - Mentions: INCY ILMN VRNA

Incyte (INCY) Teams Up with QIAGEN to Boost Blood Cancer Diagnostic Solutions

2 months ago - By: Zacks Investment Research

Here's Why Qiagen (QGEN) is a Strong Growth Stock

2 months ago - By: QIAGEN N.V.

QIAGEN and GENCURIX Announce QIAcuity Digital PCR IVD Assay Development Partnership

3 months ago - By: Yahoo Finance - Mentions: GS INCY RY RY.CA ...

Incyte (INCY) Targets $1B Growth by 2029 with New Drug Launches

3 months ago - By: QIAGEN N.V. - Mentions: INCY

QIAGEN and Incyte Announce Precision Medicine Collaboration to Develop Companion Diagnostics for Patients With Mutant CALR-expressing Myeloproliferative Neoplasms (MPNs)

3 months ago - By: Zacks Investment Research - Mentions: INCY

Qiagen (QGEN) Up 8.1% Since Last Earnings Report: Can It Continue?

3 months ago - By: Zacks Investment Research - Mentions: COR PAHC HIMS

QGEN Stock to Gain From Expanding Oncology Portfolio via New Alliances

3 months ago - By: Yahoo Finance - Mentions: VZ ASC

KeyBank adopts Personetics platform to enhance client engagement

3 months ago - By: QIAGEN N.V.

QIAGEN expands portfolio for minimal residual disease (MRD) testing in oncology with new strategic partnerships

3 months ago - By: Foresight Diagnostics, Inc.

Foresight Diagnostics and QIAGEN Announce Strategic Partnership to Advance Development of Companion Diagnostic Kits for Lymphoma

3 months ago - By: Yahoo Finance - Mentions: MRNA TGT RIO TSLA

Qiagen and ID Solutions Partner to Enhance Digital PCR Assays for Oncology Research

3 months ago - By: Zacks Investment Research - Mentions: ANGO DXCM STE

QGEN Stock Might Gain Following New Partnership With ID Solutions

3 months ago - By: QIAGEN N.V.

QIAGEN expands digital PCR oncology research portfolio through partnership with ID Solutions

4 months ago - By: Zacks Investment Research

Here's Why Qiagen (QGEN) is a Strong Momentum Stock

4 months ago - By: Zacks Investment Research - Mentions: ANGO DXCM STE

QIAGEN Stock Gains Following the Acquisition of Genoox

4 months ago - By: QIAGEN N.V.

QIAGEN enhances leading clinical genomics portfolio with acquisition of Genoox AI-powered software

4 months ago - By: Zacks Investment Research - Mentions: BSX ANGO ITGR

QGEN Q1 Earnings and Revenues Top, Operating Margin Expands, Stock Up

4 months ago - By: Zacks Investment Research

Here's What Key Metrics Tell Us About Qiagen (QGEN) Q1 Earnings

4 months ago - By: Zacks Investment Research - Mentions: YMAB

Qiagen (QGEN) Q1 Earnings and Revenues Surpass Estimates

4 months ago - By: QIAGEN N.V.

QIAGEN N.V. (QGEN) Stock News

QGEN Latest News, Press Relases and Analysis

The Role of M&A in Hologic's Growth Story: Are More Deals in Sight?

INCY Stock Trading Close to Its 52-Week High: Buy, Sell or Hold?

Why Qiagen (QGEN) International Revenue Trends Deserve Your Attention

DoorDash To Rally Around 30%? Here Are 10 Top Analyst Forecasts For Thursday

Qiagen (QGEN) Reports Q2 Earnings: What Key Metrics Have to Say

Earnings Scheduled For August 5, 2025

Qiagen (QGEN) Matches Q2 Earnings Estimates

QIAGEN exceeds outlook for Q2 2025 with solid growth and improved profitability

QIAGEN Expands NGS Portfolio with Launch of QIAseq xHYB Long Read Panels

Here's Why Qiagen (QGEN) is a Strong Value Stock

QIAGEN N.V. to Release Results for Q2 2025 and Hold Webcast

QIAGEN Announces Election of Stephen Rusckowski as Chairman of Supervisory Board

Incyte (INCY) Teams Up with QIAGEN to Boost Blood Cancer Diagnostic Solutions

Here's Why Qiagen (QGEN) is a Strong Growth Stock

QIAGEN and GENCURIX Announce QIAcuity Digital PCR IVD Assay Development Partnership

Incyte (INCY) Targets $1B Growth by 2029 with New Drug Launches

QIAGEN and Incyte Announce Precision Medicine Collaboration to Develop Companion Diagnostics for Patients With Mutant CALR-expressing Myeloproliferative Neoplasms (MPNs)

Qiagen (QGEN) Up 8.1% Since Last Earnings Report: Can It Continue?

QGEN Stock to Gain From Expanding Oncology Portfolio via New Alliances

KeyBank adopts Personetics platform to enhance client engagement

QIAGEN expands portfolio for minimal residual disease (MRD) testing in oncology with new strategic partnerships

Foresight Diagnostics and QIAGEN Announce Strategic Partnership to Advance Development of Companion Diagnostic Kits for Lymphoma

Qiagen and ID Solutions Partner to Enhance Digital PCR Assays for Oncology Research

QGEN Stock Might Gain Following New Partnership With ID Solutions

QIAGEN expands digital PCR oncology research portfolio through partnership with ID Solutions

Here's Why Qiagen (QGEN) is a Strong Momentum Stock

QIAGEN Stock Gains Following the Acquisition of Genoox

QIAGEN enhances leading clinical genomics portfolio with acquisition of Genoox AI-powered software

QGEN Q1 Earnings and Revenues Top, Operating Margin Expands, Stock Up

Here's What Key Metrics Tell Us About Qiagen (QGEN) Q1 Earnings

Qiagen (QGEN) Q1 Earnings and Revenues Surpass Estimates

QIAGEN announces plans for transition in leadership of Supervisory Board